ASCO 2023: New drug combination twice as effective for some ovarian cancer patients as next best treatment 04 Jun 2023 A targeted drug combination for patients with a type of ovarian cancer could be nearly twice as effective as the next best treatment, according to interim results from a phase II study. Find out more Show/Hide
ASCO 2022: 'Practice-changing' radiotherapy technique can reduce swallowing problems for cancer patients 13 Jun 2022 A new precision radiotherapy technique described as ‘practice changing’ has been shown to reduce long-term side effects, including swallowing problems, for patients with head and neck cancer following treatment. Find out more Show/Hide
ASCO 2022: Drug combination shows promise against cancer’s ‘death star’ protein 03 Jun 2022 A drug combination targeting multiple mutant versions of cancer’s ‘death star’ protein has shown promise in a small, early-phase clinical trial for some patients with advanced lung, ovarian and thyroid cancer. Find out more Show/Hide
ASCO 2021: Trial shows benefits of targeted drug against early-stage breast cancer with inherited BRCA mutation 03 Jun 2021
ASCO 2020: New optimised precision radiotherapy can reduce swallowing difficulties for head and neck cancer patients 30 May 2020
ASCO 2019: Breast cancer drug effective in 80 per cent of men with BRCA-mutant prostate cancer 05 Jun 2019